10 unique reagents that helped advance research in 2018

At Kerafast, it’s become an annual tradition at the start of each year to look back at how the reagents in our catalog have helped contribute to scientific progress. Our company mission is to facilitate access to the unique reagents developed by academic laboratories. Together with our providing investigators, we get lab-made reagents out of 

Continue Reading…

Cell-Based Meat Gears Up for Public Market

International and bay-area startups are in a R&D race to bring cell-based meat (also known as clean meat, cultured meat and in vitro meat) to market. At its core, the concept of cell-based meat is fairly straightforward: myoblast stem cells are cultured and directed to form myocytes, which may then be compacted to form ground 

Continue Reading…

Giving Back During the Holidays

This holiday season, the Kerafast team decided to give back to our local community by adopting an apartment at the Ronald McDonald House at Boston Harbor, where families of critically ill children can stay while their child receives care at a Boston-area treatment center. The organization provides lodging and support to these families, striving to 

Continue Reading…

Studying insulin signaling using trans-omic analysis

University of Tokyo researchers have shown different insulin concentrations activate different cell signaling pathways, findings that may lead to better treatments for diabetes. The researchers tracked the effects of insulin using a trans-omics approach, combining multiple databases and large-scale experiments, and published their results in the journal iScience. We were excited to see our puromycin 

Continue Reading…

New heart disease genetic risk factor discovered

Atherosclerotic disease – the narrowing of arteries due to plaque buildup – is a leading cause of death worldwide. It causes 15 million lives to be lost each year around the world, with 610,000 deaths estimated in the United States alone. In a new study, researchers have pinpointed one more reason why some people are 

Continue Reading…

Using a gut-on-a-chip model to study intestinal inflammation

Intestinal inflammation involves a complex interaction between intestinal epithelial cells, intestinal microbiota and immune cells. Many factors are known to be involved in the onset of intestinal inflammation; however, an inciting factor responsible for triggering inflammation has not been identified. The ability to identify an inciting factor has been hampered by the lack of animal-based 

Continue Reading…

Freeze-dried polio vaccine could end the disease

University of Southern California researchers have developed an injectable freeze-dried polio vaccine that can be kept at room temperature in powder form for four weeks and then rehydrated without losing efficacy in mice. Because the vaccine doesn’t need refrigeration, it could potentially be used throughout more remote parts of the world where polio still lurks, 

Continue Reading…

We’ve moved! Take a tour of our new office

The Kerafast team has now officially moved into our new office space! We’re still in the same building, located on the water in Boston’s Innovation District. We’re even on the same floor, so our address remains the same. However, we’ve excited to have upgraded to a larger space, complete with a bigger lab and shipping 

Continue Reading…

Fighting infection with antibacterial drones

The prevalence of antibiotic-resistant bacteria is an ever-growing problem that poses a significant threat to global health. An increasing number of infectious diseases are becoming more difficult, and in some cases impossible, to treat. While new antibiotics are being developed, it is unlikely that they will be effective against the most dangerous antibiotic-resistant bacteria. To 

Continue Reading…